Arthritis augments breast cancer metastasis: Role of mast cells and SCF/c-Kit signaling

Breast Cancer Research

Volumn 15, Issue 2, 2013, Pages

  Roy, Lopamudra Das ^a   Curry, Jennifer M ^a   Sahraei, Mahnaz ^b   Besmer, Dahlia M ^a   Kidiyoor, Amritha ^a   Gruber, Helen E ^c   Mukherjee, Pinku ^a  

^a UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CAROLINAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CELL; CANCER INCIDENCE; CELL DIFFERENTIATION; CELL POPULATION; CONTROLLED STUDY; LUNG METASTASIS; MAST CELL; METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 84878161963     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3412     Document Type: Article

References (55)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62:10-29. 10.3322/caac.20138, 22237781.
2. de Visser KE, Coussens LM. The inflammatory tumor microenvironment and its impact on cancer development. Contrib Microbiol 2006, 13:118-137.
3. Azim H, Azim HA. Targeting RANKL in breast cancer: bone metastasis and beyond. Expert Rev Anticancer Ther 2013, 13:195-201. 10.1586/era.12.177, 23406560.
4. Futakuchi M, Singh RK. Animal model for mammary tumor growth in the bone microenvironment. Breast Cancer 2013
5. Sosnoski DM, Krishnan V, Kraemer WJ, Dunn-Lewis C, Mastro AM. Changes in cytokines of the bone microenvironment during breast cancer metastasis. Int J Breast Cancer 2012, 2012:160265. 3270522, 22315691.
6. Majithia V, Geraci SA. Rheumatoid arthritis: diagnosis and management. Am J Med 2007, 120:936-939. 10.1016/j.amjmed.2007.04.005, 17976416.
7. Ji J, Liu X, Sundquist K, Sundquist J. Survival of cancer in patients with rheumatoid arthritis: a follow-up study in Sweden of patients hospitalized with rheumatoid arthritis 1 year before diagnosis of cancer. Rheumatology (Oxford) 2011, 50:1513-1518.
8. Das Roy L, Pathangey L, Tinder T, Schettini J, Gruber H, Mukherjee P. Breast cancer-associated metastasis is significantly increased in a model of autoimmune arthritis. Breast Cancer Res 2009, 11:R56. 10.1186/bcr2345, 2750117, 19643025.
9. Das Roy L, Ghosh S, Pathangey LB, Tinder TL, Gruber HE, Mukherjee P. Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancer. BMC Cancer 2011, 11:365. 10.1186/1471-2407-11-365, 3224388, 21859454.
10. Huang B, Lei Z, Zhang GM, Li D, Song C, Li B, Liu Y, Yuan Y, Unkeless J, Xiong H, Feng ZH. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 2008, 112:1269-1279. 10.1182/blood-2008-03-147033, 2515142, 18524989.
11. Kinet JP. The essential role of mast cells in orchestrating inflammation. Immunol Rev 2007, 217:5-7. 10.1111/j.1600-065X.2007.00528.x, 17498047.
12. Metz M, Grimbaldeston MA, Nakae S, Piliponsky AM, Tsai M, Galli SJ. Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 2007, 217:304-328. 10.1111/j.1600-065X.2007.00520.x, 17498068.
13. Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, Sakihama T, Matsutani T, Negishi I, Nakatsuru S, Sakaguchi S. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003, 426:454-460. 10.1038/nature02119, 14647385.
14. Hata H, Sakaguchi N, Yoshitomi H, Iwakura Y, Sekikawa K, Azuma Y, Kanai C, Moriizumi E, Nomura T, Nakamura T, Sakaguchi S. Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest 2004, 114:582-588. 503774, 15314695.
15. Firestein G. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361. 10.1038/nature01661, 12748655.
16. Maglione JE, Moghanaki D, Young LJ, Manner CK, Ellies LG, Joseph SO, Nicholson B, Cardiff RD, MacLeod CL. Transgenic polyoma middle-T mice model premalignant mammary disease. Cancer Res 2001, 61:8298-8305.
17. Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 1992, 12:954-961. 369527, 1312220.
18. Brand D, Latham K, Rosloniec E. Collagen-induced arthritis. Nat Protoc 2007, 2:1269-1275. 10.1038/nprot.2007.173, 17546023.
19. Fournier C. Where do T cells stand in rheumatoid arthritis?. Joint Bone Spine 2005, 72:527-532. 10.1016/j.jbspin.2004.12.012, 16087382.
20. Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, Sakihama T, Matsutani T, Negishi I, Nakatsuru S, Sakaguchi S. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003, 426:454-460. 10.1038/nature02119, 14647385.
21. Mukherjee P, Madsen CS, Ginardi AR, Tinder TL, Jacobs F, Parker J, Agrawal B, Longenecker BM, Gendler SJ. Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer. J Immunother 2003, 26:47-62. 10.1097/00002371-200301000-00006, 12514429.
22. Basu GD, Tinder TL, Bradley JM, Tu T, Hattrup CL, Pockaj BA, Mukherjee P. Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: role of IDO. J Immunol 2006, 177:2391-2402.
23. Basu G, Pathangey L, Tinder T, LaGioia M, Gendler S, Mukherjee P. COX-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer. Mol Cancer Res 2004, 2:632-642.
24. Chen D, Xia J, Tanaka Y, Chen H, Koido S, Wernet O, Mukherjee P, Gendler SJ, Kufe D, Gong J. Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells. Immunology 2003, 109:300-307. 10.1046/j.1365-2567.2003.01656.x, 1782954, 12757626.
25. Tao K, Fang M, Alroy J, Sahagian GG. Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer 2008, 8:228. 10.1186/1471-2407-8-228, 2529338, 18691423.
26. Nakamori M, Fu X, Rousseau R, Chen SY, Zhang X. Destruction of nonimmunogenic mammary tumor cells by a fusogenic oncolytic herpes simplex virus induces potent antitumor immunity. Mol Ther 2004, 9:658-665. 10.1016/j.ymthe.2004.02.019, 15120326.
27. Li H, Dutuor A, Fu X, Zhang X. Induction of strong antitumor immunity by an HSV-2-based oncolytic virus in a murine mammary tumor model. J Gene Med 2007, 9:161-169. 10.1002/jgm.1005, 17266169.
28. Brand DD, Latham KA, Rosloniec EF. Collagen-induced arthritis. Nat Protoc 2007, 2:1269-1275. 10.1038/nprot.2007.173, 17546023.
29. Roy LD, Sahraei M, Subramani DB, Besmer D, Nath S, Tinder TL, Bajaj E, Shanmugam K, Lee YY, Hwang SI, Gendler SJ, Mukherjee P. MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition. Oncogene 2011, 30:1449-1459. 10.1038/onc.2010.526, 3063863, 21102519.
30. Lee HN, Kim CH, Song GG, Cho SW. Effects of IL-3 and SCF on histamine production kinetics and cell phenotype in rat bone marrow-derived mast cells. Immune Netw 2010, 10:15-25. 10.4110/in.2010.10.1.15, 2837153, 20228932.
31. Glinskii AB, Smith BA, Jiang P, Li XM, Yang M, Hoffman RM, Glinsky GV. Viable circulating metastatic cells produced in orthotopic but not ectopic prostate cancer models. Cancer Res 2003, 63:4239-4243.
32. Woo M, Nordal R. Commissioning and evaluation of a new commercial small rodent x-ray irradiator. Biomed Imaging Intervent J 2006, 2:1-5.
33. Tanaka T, McRae BJ, Cho K, Cook R, Fraki JE, Johnson DA, Powers JC. Mammalian tissue trypsin-like enzymes: comparative reactivities of human skin tryptase, human lung tryptase, and bovine trypsin with peptide 4-nitroanilide and thioester substrates. J Biol Chem 1983, 258:13552-13557.
34. Vanderslice P, Ballinger SM, Tam EK, Goldstein SM, Craik CS, Caughey GH. Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. Proc Natl Acad Sci USA 1990, 87:3811-3815. 10.1073/pnas.87.10.3811, 53993, 2187193.
35. Ludolph-Hauser D, Rueff F, Sommerhoff CP, Przybilla B. Tryptase, a marker for the activation and localization of mast cells. Hautarzt 1999, 50:556-561. 10.1007/s001050050958, 10460298.
36. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ, Suda T. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999, 103:1345-1352. 10.1172/JCI5703, 408356, 10225978.
37. Arun B, Goss P. The role of COX-2 inhibition in breast cancer treatment and prevention. Semin Oncol 2004, 31:22-29.
38. Ziegler J. Cancer and arthritis share underlying processes. J Natl Cancer Inst 1998, 90:802-803. 10.1093/jnci/90.11.802, 9625164.
39. Coussens L, Werb Z. Inflammation and cancer. Nature 2002, 420:860-867. 10.1038/nature01322, 2803035, 12490959.
40. Philip M, Rowley D, Schreiber H. Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol 2004, 14:433-439. 10.1016/j.semcancer.2004.06.006, 15489136.
41. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27-31. 10.1038/nm0195-27, 7584949.
42. Seki M, Uzuki M, Ohmoto H, Yoshino K, Maeda S, Kokubun S, Sakurai M, Sawai T. Matrix metalloproteinase (MMP-9) in patients with rheumatoid arthritis. Ryumachi 1995, 35:792-801.
43. Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, Chwalinska-Sadowska H, Maslinski W. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 2000, 164:2832-2838.
44. Tilg H, Kaser A. IL-6 and arthritis: a detrimental or beneficial mediator?. IDrugs 1998, 1:890-895.
45. Ben-Baruch A. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Semin Cancer Biol 2006, 16:38-52. 10.1016/j.semcancer.2005.07.006, 16139507.
46. Sansone P, Storci G, Tavolari S, Guarnieri T, Giovannini C, Taffurelli M, Ceccarelli C, Santini D, Paterini P, Marcu KB, Chieco P, Bonafè M. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest 2007, 117:3988-4002. 10.1172/JCI32533, 2096439, 18060036.
47. Nam JS, Terabe M, Kang MJ, Chae H, Voong N, Yang YA, Laurence A, Michalowska A, Mamura M, Lonning S, Berzofsky JA, Wakefield LM. Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Res 2008, 68:3915-3923. 10.1158/0008-5472.CAN-08-0206, 2586596, 18483277.
48. Juurikivi A, Sandler C, Lindstedt KA, Kovanen PT, Juutilainen T, Leskinen MJ, Maki T, Eklund KK. Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis. Ann Rheum Dis 2005, 64:1126-1131. 10.1136/ard.2004.029835, 1755598, 16014680.
49. Kuonen F, Laurent J, Secondini C, Lorusso G, Stehle JC, Rausch T, Faes-Van't Hull E, Bieler G, Alghisi GC, Schwendener R, Andrejevic-Blant S, Mirimanoff RO, Rüegg C. Inhibition of the Kit ligand/c-Kit axis attenuates metastasis in a mouse model mimicking local breast cancer relapse after radiotherapy. Clin Cancer Res 2012, 18:4365-4374. 10.1158/1078-0432.CCR-11-3028, 22711708.
50. Ceponis A, Konttinen YT, Takagi M, Xu JW, Sorsa T, Matucci-Cerinic M, Santavirta S, Bankl HC, Valent P. Expression of stem cell factor (SCF) and SCF receptor (c-kit) in synovial membrane in arthritis: correlation with synovial mast cell hyperplasia and inflammation. J Rheumatol 1998, 25:2304-2314.
51. Galli SJ, Tsai M, Wershil BK. The c-kit receptor, stem cell factor, and mast cells: what each is teaching us about the others. Am J Pathol 1993, 142:965-974. 1886888, 7682764.
52. Bridges AJ, Malone DG, Jicinsky J, Chen M, Ory P, Engber W, Graziano FM. Human synovial mast cell involvement in rheumatoid arthritis and osteoarthritis: relationship to disease type, clinical activity, and antirheumatic therapy. Arthritis Rheum 1991, 34:1116-1124. 10.1002/art.1780340907, 1930330.
53. Dean G, Hoyland JA, Denton J, Donn RP, Freemont AJ. Mast cells in the synovium and synovial fluid in osteoarthritis. Br J Rheumatol 1993, 32:671-675. 10.1093/rheumatology/32.8.671, 8348268.
54. Theoharides TC, Conti P. Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol 2004, 25:235-241. 10.1016/j.it.2004.02.013, 15099563.
55. Xiang M, Gu Y, Zhao F, Lu H, Chen S, Yin L. Mast cell tryptase promotes breast cancer migration and invasion. Oncol Rep 2010, 23:615-619.